TURBO ANTIOQUIA, Colombia, Oct. 13, 2017 -- Inca Worldwide (OTC-Pink:QEDN) announces the development of the first Sacha Inchi Milk with all the Omega 3,6,9, and a complete protein. This milk looks like real cow milk and is the only milk with the required amount of Omega 3,6,9 for a healthy diet and a similar taste to cow milk.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/113188c5-b7a3-4106-b4b3-22216c136d24
Kate Bahnsen comments, “We are very happy to be able to bring to the market a product that will substitute cow milk, almond milk and soya milk. We believe this milk will be a very big seller and will position our company as a leader in the milk industry, an industry that is expected to grow to $35.06 Billion USD in 2024.”
Contact information: [email protected]
About Inca Worldwide
Our Inca Seeds (Roasted Sacha Inchi) are a complete protein with all 9-essential amino-acids rich in Omega 3, 6 & 9 and an antioxidant, a real Super-food.
www.incaworldwide.com
Caution Concerning Forward-Looking Statements:
Our public communications and SEC filings may contain "forward-looking statements" – that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," or "target."
Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about our announced plan to reduce the size of our financial services businesses, including expected cash and non-cash charges associated with this plan and earnings per share of QED retained businesses (Verticals); expected income; earnings per share; revenues; organic growth; growth and productivity associated with our Digital business; margins; cost structure; restructuring charges; acquisition-related synergies; cash flows; returns on capital and investment; capital expenditures, capital allocation or capital structure; and dividends.


Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 



